Olympus Corp
(OTC: OLYMY)
|
4:50 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $15.91 | Change: +0.24 | %Change: +1.53% | Volume: 13,946 |
Open: | $ 15.89 | Volume: | 13,946 | |
---|---|---|---|---|
High: | $ 15.91 | Yield(%) | 0.73 | |
Low: | $ 15.84 | P/E Ratio (ttm): | 11.33 | |
Dividend ($): | 0.08 | Market Cap ($): | 17.67B | |
EPS ($) | 1.41 | Shares Out: | 1.13B |
% Price Change (last 4 weeks): | -3.44 |
---|---|
% Price Change (last 13 weeks): | 10.88 |
% Price Change (last 26 weeks): | 8.95 |
% Price Change (last 52 weeks): | -2.16 |
% Price Change (year to date): | 8.19 |
Return on Equity (%): | 3.75 |
---|---|
Return on Assets (%): | 1.71 |
Return on Invested Capital (%): | 9.90 |
Gross Profit Margin (%): | 63.00 |
---|---|
Net Profit Margin (%): | 2.84 |
Operating Profit Margin (%): | 16.00 |
|
|
50-day Moving Average: | $15.66 |
---|---|
200-day Moving Average: | $14.53 |
Avg. Daily Vol. (last 50 days): | 41,564 |
Avg. Daily Vol. (last 200 days): | 84,082 |
52-wk high: | $17.53 |
52-wk low: | $11.91 |
Bid: | $n/a |
Ask: | $n/a |
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
|
Olympus Corp
Shinjuku Monolith 2-3-1 Nishi-Shinjuku Shinjuku-Ku Tokyo TY 163-0914 Phone: 81.3.3340.2111 Fax: 81.3.3340.2062 http://www.olympus.co.jp |
Earnings (1year) ($): | 1.41 |
---|---|
Annual Dividend ($): | 0.12 |
Current P/E Ratio (ttm): | 11.33 |
Book Value ($): | 4.29 |
Cash Flow ($): | 1.83 |
Price/Earnings (x): | 11.33 |
---|---|
Price/Sales (x): | 2.70 |
Price/Book (x): | 3.35 |
Price/Cash Flow (x): | 59.62 |
Quick Ratio (x): | 1.41 |
---|---|
Current Ratio (x): | 1.85 |
LT Debt/Equity (x): | 36.51 |
Total Debt/Equity (x): | 47.62 |